全文获取类型
收费全文 | 2659898篇 |
免费 | 194319篇 |
国内免费 | 5318篇 |
专业分类
耳鼻咽喉 | 36593篇 |
儿科学 | 89072篇 |
妇产科学 | 72857篇 |
基础医学 | 376143篇 |
口腔科学 | 74991篇 |
临床医学 | 237309篇 |
内科学 | 521866篇 |
皮肤病学 | 59440篇 |
神经病学 | 206987篇 |
特种医学 | 102916篇 |
外国民族医学 | 873篇 |
外科学 | 405748篇 |
综合类 | 60171篇 |
现状与发展 | 5篇 |
一般理论 | 851篇 |
预防医学 | 199362篇 |
眼科学 | 62392篇 |
药学 | 195796篇 |
12篇 | |
中国医学 | 6289篇 |
肿瘤学 | 149862篇 |
出版年
2019年 | 20316篇 |
2018年 | 29350篇 |
2017年 | 22209篇 |
2016年 | 24454篇 |
2015年 | 27795篇 |
2014年 | 38709篇 |
2013年 | 57498篇 |
2012年 | 79317篇 |
2011年 | 83756篇 |
2010年 | 49930篇 |
2009年 | 46899篇 |
2008年 | 78669篇 |
2007年 | 83758篇 |
2006年 | 84444篇 |
2005年 | 81221篇 |
2004年 | 78921篇 |
2003年 | 75625篇 |
2002年 | 73354篇 |
2001年 | 134183篇 |
2000年 | 137890篇 |
1999年 | 115665篇 |
1998年 | 31035篇 |
1997年 | 27507篇 |
1996年 | 27806篇 |
1995年 | 26614篇 |
1994年 | 24720篇 |
1993年 | 22857篇 |
1992年 | 89485篇 |
1991年 | 86961篇 |
1990年 | 84084篇 |
1989年 | 80618篇 |
1988年 | 73865篇 |
1987年 | 72447篇 |
1986年 | 67874篇 |
1985年 | 64611篇 |
1984年 | 48040篇 |
1983年 | 40660篇 |
1982年 | 23153篇 |
1981年 | 20845篇 |
1979年 | 42577篇 |
1978年 | 29458篇 |
1977年 | 25088篇 |
1976年 | 23344篇 |
1975年 | 25048篇 |
1974年 | 29917篇 |
1973年 | 28562篇 |
1972年 | 26556篇 |
1971年 | 24252篇 |
1970年 | 22726篇 |
1969年 | 21000篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
J. Rodríguez-Carrio A. Martínez-Zapico I. Cabezas-Rodríguez L. Benavente Á.I. Pérez-Álvarez P. López J.B. Cannata-Andía M. Naves-Díaz A. Suárez 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2019,29(2):135-143
Background and aims
Since accelerated atherosclerosis has been reported in systemic lupus erythematosus (SLE), predictive biomarkers of cardiovascular disease (CVD) are needed. Among non-traditional risk factors, bone mineral density (BMD) has been related to CVD. However, its role in SLE remains controversial. This study aims to analyze the associations of subclinical atherosclerosis with traditional and non-traditional CV risk factors.Methods and results
In a cross-sectional study, atherosclerosis burden was compared between 112 female SLE patients and 31 controls. Plaque number and carotid intima-media wall thickness (cIMT) were assessed by ultrasonography. In a retrospective study, BMD determinations obtained 5-years before the ultrasonography assessment were analyzed in a subgroup of 62 patients. Plaque frequency was increased in SLE, even in patients without CV events or carotid wall thickening. cIMT was increased in patients with CVD, positively correlated with body mass index (BMI). Interestingly, a paradoxical effect of BMI on carotid parameters was observed. Whereas underweight patients (BMI < 20) showed increased prevalence of carotid plaques with low cIMT, those with BMI > 30 showed higher cIMT and plaque burden. Overweight patients (25 < BMI<30) exhibited both elevated cIMT and plaque number. BMI was an independent predictor of BMD. In our retrospective study, patients with either clinical or subclinical CVD exhibited lower BMD levels than their CV-free counterparts. A low lumbar spine BMD independently predicted CVD development after adjusting for confounders.Conclusion
SLE was associated with a higher subclinical atherosclerosis burden, a bimodal effect being observed for BMI. Decreased BMD can be a CV risk biomarker in SLE. 相似文献23.
24.
Bernard–Soulier syndrome (BSS) is a rare autosomal recessively inherited bleeding disorder. Pregnancy in patients with BSS is characterized by ante‐, intra‐, or postpartum haemorrhage, which may be delayed and severe. There is no consensus in the management of BSS in pregnancy and so far only 16 pregnancies in nine patients have been described. We report a further three pregnancies in two women with the syndrome. We also outline our management of pregnant patients with BSS. 相似文献
25.
Lalia Y. Ibrahim Krank P. DiFilippo Geremy E. Steed Manuel D. Cerqueira 《Journal of nuclear cardiology》2006,13(6):855-866
Conclusion Several quality-control measures take place before (patient and camera preparation) and during SPECT acquisition to achieve
high-quality images. Not uncommonly, technologists and physicians are left with suboptimal images that have to be addressed
to reach the “right answer” for patient diagnosis and hence management. In many cases patients may be reimaged, especially
if the problem is detected early, but in other cases either the patient has left the nuclear laboratory or there is an inevitable
problem that, even with reimaging, will not be resolved. In these situations the technologist and physician have to seek the
available techniques to obtain the best images possible. These resources are discussed in this issue as an aid in quality
control to obtain the best possible images. 相似文献
26.
27.
28.
29.
30.
A Kotsiou M Tsamouri S Anagnostopoulou M Tzivras E Vairactaris C Tesseromatis 《European journal of drug metabolism and pharmacokinetics》2006,31(2):97-101
Liver disease alters the pharmacokinetic and pharmacodynamic properties of hepatically eliminated drugs. The main factors influenced are plasma albumin levels, enzyme balance (induction & inhibition) and drug binding to tissue proteins. The influence of lidocaine on serum, heart and liver propranolol levels in Wistar rats after liver injury induced by carbon tetrachloride CCl4 0.4 ml/kg x 2/wkl, was investigated. 40 male Wistar rats were divided into four groups (I, II, III, IV; n=10), Group I animals received only propranolol (labelled + cold substance) 40 mg/kg/12 h p.o., group II propranolol plus lidocaine in a single dose of 4mg/kg s.c., group III was treated with CCl4 for 6 weeks and received propranolol x2 at the same dosage as group I, while group VI was treated with CCl4 and the same drug dosage as group II. The simultaneous administration of H3-propranolol and lidocaine increased propranolol levels in the serum and tissues. The liver in damaged animals showed an increase of propranolol level under lidocaine co-administration, probably due to CCl4 induced liver enzyme activity, resulting in a rapid propranolol metabolism or to competition between both drug protein binding sites. The increased propranolol levels in the heart after lidocaine administration were probably due to attributed to its high affinity for heart tissue. Consequently, as regards the therapeutic approach for patients with liver disease receiving propranolol their propranolol dosage should be reduced when lidocaine is co-administered. 相似文献